{"transactions":[{"id":1427758,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-08-20T10:15:03.000Z","date":"2024-08-16","kind":"other","planned":false,"acquired":false,"shares":7631418,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Also on August 16, 2024, following the TOI HC 1 Distribution, Havencrest Healthcare Partners, L.P. made a further pro-rata in-kind distribution of the 7,631,418 shares it received in the TOI HC 1 Distribution to its limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the \"Havencrest LP Distribution\"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 152,626 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Also on August 16, 2024, following the TOI HC 1 Distribution, Havencrest Healthcare Partners, L.P. made a further pro-rata in-kind distribution of the 7,631,418 shares it received in the TOI HC 1 Distribution to its limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the \"Havencrest LP Distribution\"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 152,626 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Also on August 16, 2024, following the TOI HC 1 Distribution, Havencrest Healthcare Partners, L.P. made a further pro-rata in-kind distribution of the 7,631,418 shares it received in the TOI HC 1 Distribution to its limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the \"Havencrest LP Distribution\"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 152,626 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":252626,"source":{"system":"sec-edgar","filing":"0000950170-24-098843","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000095017024098843/ownership.xml","form_type":"4"}},{"id":1427757,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-08-20T10:15:03.000Z","date":"2024-08-16","kind":"other","planned":false,"acquired":false,"shares":8701823,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 16, 2024, TOI HC I, LLC distributed an aggregate of 8,701,823 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the \"TOI HC 1 Distribution\"). Immediately following the TOI HC 1 Distribution, Havencrest Healthcare Partners GP, LLC (the \"General Partner\") was the record holder of 7,631,418 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 16, 2024, TOI HC I, LLC distributed an aggregate of 8,701,823 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the \"TOI HC 1 Distribution\"). Immediately following the TOI HC 1 Distribution, Havencrest Healthcare Partners GP, LLC (the \"General Partner\") was the record holder of 7,631,418 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On August 16, 2024, TOI HC I, LLC distributed an aggregate of 8,701,823 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the \"TOI HC 1 Distribution\"). Immediately following the TOI HC 1 Distribution, Havencrest Healthcare Partners GP, LLC (the \"General Partner\") was the record holder of 7,631,418 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":7884044,"source":{"system":"sec-edgar","filing":"0000950170-24-098843","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000095017024098843/ownership.xml","form_type":"4"}},{"id":1666603,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-31T00:07:24.000Z","date":"2024-01-29","kind":"sale","planned":false,"acquired":false,"shares":8637,"price":2.12,"value":18310.44,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.19, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Havencrest Healthcare Partners GP, LLC (the \"General Partner\") is the record holder of these shares of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-009050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000095017024009050/ownership.xml","form_type":"4"}},{"id":1669719,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-27T00:19:29.000Z","date":"2024-01-26","kind":"sale","planned":false,"acquired":false,"shares":6979,"price":2.14,"value":14935.06,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.09 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Havencrest Healthcare Partners GP, LLC (the \"General Partner\") is the record holder of these shares of the Issuer's common stock."}],"balance_after":8637,"source":{"system":"sec-edgar","filing":"0000899243-24-000121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924324000121/doc4.xml","form_type":"4"}},{"id":1669718,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-27T00:19:29.000Z","date":"2024-01-25","kind":"sale","planned":false,"acquired":false,"shares":11882,"price":2.07,"value":24595.74,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Havencrest Healthcare Partners GP, LLC (the \"General Partner\") is the record holder of these shares of the Issuer's common stock."}],"balance_after":15616,"source":{"system":"sec-edgar","filing":"0000899243-24-000121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924324000121/doc4.xml","form_type":"4"}},{"id":1669717,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-27T00:19:29.000Z","date":"2024-01-24","kind":"sale","planned":false,"acquired":false,"shares":24915,"price":2.3,"value":57304.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.44, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Havencrest Healthcare Partners GP, LLC (the \"General Partner\") is the record holder of these shares of the Issuer's common stock."}],"balance_after":27498,"source":{"system":"sec-edgar","filing":"0000899243-24-000121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924324000121/doc4.xml","form_type":"4"}},{"id":1673132,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-24T01:02:06.000Z","date":"2024-01-23","kind":"sale","planned":false,"acquired":false,"shares":5338,"price":2.11,"value":11263.18,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.08 to $2.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Havencrest Healthcare Partners GP, LLC (the \"General Partner\") is the record holder of these shares of the Issuer's common stock."}],"balance_after":52413,"source":{"system":"sec-edgar","filing":"0000899243-24-000108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924324000108/doc4.xml","form_type":"4"}},{"id":1673131,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-24T01:02:06.000Z","date":"2024-01-22","kind":"sale","planned":false,"acquired":false,"shares":10263,"price":2.12,"value":21757.56,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.08 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Havencrest Healthcare Partners GP, LLC (the \"General Partner\") is the record holder of these shares of the Issuer's common stock."}],"balance_after":57751,"source":{"system":"sec-edgar","filing":"0000899243-24-000108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924324000108/doc4.xml","form_type":"4"}},{"id":1673130,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-24T01:02:06.000Z","date":"2024-01-19","kind":"sale","planned":false,"acquired":false,"shares":11986,"price":2.13,"value":25530.18,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.19, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Havencrest Healthcare Partners GP, LLC (the \"General Partner\") is the record holder of these shares of the Issuer's common stock."}],"balance_after":68014,"source":{"system":"sec-edgar","filing":"0000899243-24-000108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924324000108/doc4.xml","form_type":"4"}},{"id":1696589,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-02T22:01:56.000Z","date":"2023-12-28","kind":"other","planned":false,"acquired":false,"shares":3999998,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Also on December 28, 2023, following the TOI HC I Distribution, the General Partner, on behalf of Havencrest Healthcare Partners, L.P., made a further pro-rata in-kind distribution of the 3,999,998 shares Havencrest Healthcare Partners, L.P.  received in the TOI HC I Distribution to Havencrest Healthcare Partners, L.P.'s limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the \"Havencrest LP Distribution\"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 80,000 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from footnote 2)  Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Also on December 28, 2023, following the TOI HC I Distribution, the General Partner, on behalf of Havencrest Healthcare Partners, L.P., made a further pro-rata in-kind distribution of the 3,999,998 shares Havencrest Healthcare Partners, L.P.  received in the TOI HC I Distribution to Havencrest Healthcare Partners, L.P.'s limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the \"Havencrest LP Distribution\"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 80,000 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from footnote 2)  Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Also on December 28, 2023, following the TOI HC I Distribution, the General Partner, on behalf of Havencrest Healthcare Partners, L.P., made a further pro-rata in-kind distribution of the 3,999,998 shares Havencrest Healthcare Partners, L.P.  received in the TOI HC I Distribution to Havencrest Healthcare Partners, L.P.'s limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the \"Havencrest LP Distribution\"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 80,000 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from footnote 2)  Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":8881823,"source":{"system":"sec-edgar","filing":"0000950170-24-000345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000095017024000345/ownership.xml","form_type":"4"}},{"id":1696588,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2024-01-02T22:01:56.000Z","date":"2023-12-28","kind":"other","planned":false,"acquired":false,"shares":4561050,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 28, 2023, TOI HC I, LLC distributed an aggregate of 4,561,050 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the \"TOI HC I Distribution\"). Immediately following the TOI HC I Distribution, Havencrest Healthcare Partners GP, LLC (the \"General Partner\") was the record holder of 3,999,998 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 28, 2023, TOI HC I, LLC distributed an aggregate of 4,561,050 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the \"TOI HC I Distribution\"). Immediately following the TOI HC I Distribution, Havencrest Healthcare Partners GP, LLC (the \"General Partner\") was the record holder of 3,999,998 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On December 28, 2023, TOI HC I, LLC distributed an aggregate of 4,561,050 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the \"TOI HC I Distribution\"). Immediately following the TOI HC I Distribution, Havencrest Healthcare Partners GP, LLC (the \"General Partner\") was the record holder of 3,999,998 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":12801821,"source":{"system":"sec-edgar","filing":"0000950170-24-000345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000095017024000345/ownership.xml","form_type":"4"}},{"id":2116277,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-16T02:30:19.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":365321,"price":2.33,"value":851197.93,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.74, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":13362873,"source":{"system":"sec-edgar","filing":"0000899243-22-035946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322035946/doc4.xml","form_type":"4"}},{"id":2120114,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-11T02:30:25.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":61281,"price":2.98,"value":182617.38,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.62 to $3.30, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":13728194,"source":{"system":"sec-edgar","filing":"0000899243-22-035588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322035588/doc4.xml","form_type":"4"}},{"id":2120113,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-11T02:30:25.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":80000,"price":3.09,"value":247200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.91 to $3.23, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":13789475,"source":{"system":"sec-edgar","filing":"0000899243-22-035588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322035588/doc4.xml","form_type":"4"}},{"id":2120112,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-11T02:30:25.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":27000,"price":3.24,"value":87480.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.38, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":13869475,"source":{"system":"sec-edgar","filing":"0000899243-22-035588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322035588/doc4.xml","form_type":"4"}},{"id":2123518,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-08T02:30:10.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":19167,"price":3.28,"value":62867.76,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.21 to $3.39, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":13896475,"source":{"system":"sec-edgar","filing":"0000899243-22-035320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322035320/doc4.xml","form_type":"4"}},{"id":2123517,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-08T02:30:10.000Z","date":"2022-11-04","kind":"sale","acquired":false,"shares":50200,"price":3.39,"value":170178.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.57, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":13915642,"source":{"system":"sec-edgar","filing":"0000899243-22-035320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322035320/doc4.xml","form_type":"4"}},{"id":2123516,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-08T02:30:10.000Z","date":"2022-11-03","kind":"sale","acquired":false,"shares":45500,"price":3.58,"value":162890.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.46 to $3.85, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":13965842,"source":{"system":"sec-edgar","filing":"0000899243-22-035320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322035320/doc4.xml","form_type":"4"}},{"id":2127240,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-03T01:30:12.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":58500,"price":3.94,"value":230490.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $4.17, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14011342,"source":{"system":"sec-edgar","filing":"0000899243-22-034844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034844/doc4.xml","form_type":"4"}},{"id":2127239,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-03T01:30:12.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":50272,"price":4.26,"value":214158.72,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.08 to $4.69, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14069842,"source":{"system":"sec-edgar","filing":"0000899243-22-034844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034844/doc4.xml","form_type":"4"}},{"id":2127238,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-11-03T01:30:12.000Z","date":"2022-10-31","kind":"sale","acquired":false,"shares":41855,"price":4.69,"value":196299.95,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.83, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14120114,"source":{"system":"sec-edgar","filing":"0000899243-22-034844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034844/doc4.xml","form_type":"4"}},{"id":2130409,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-29T01:30:24.000Z","date":"2022-10-28","kind":"sale","acquired":false,"shares":52091,"price":4.84,"value":252120.44,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.55 to $5.03, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14161969,"source":{"system":"sec-edgar","filing":"0000899243-22-034501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034501/doc4.xml","form_type":"4"}},{"id":2130408,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-29T01:30:24.000Z","date":"2022-10-27","kind":"sale","acquired":false,"shares":35000,"price":5.09,"value":178150.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.95 to $5.16, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14214060,"source":{"system":"sec-edgar","filing":"0000899243-22-034501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034501/doc4.xml","form_type":"4"}},{"id":2130407,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-29T01:30:24.000Z","date":"2022-10-26","kind":"sale","acquired":false,"shares":52500,"price":5.16,"value":270900.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.94 to $5.30, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14249060,"source":{"system":"sec-edgar","filing":"0000899243-22-034501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034501/doc4.xml","form_type":"4"}},{"id":2132389,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-26T01:30:13.000Z","date":"2022-10-25","kind":"sale","acquired":false,"shares":30400,"price":5.1,"value":155040.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.80 to $5.34, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14301560,"source":{"system":"sec-edgar","filing":"0000899243-22-034156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034156/doc4.xml","form_type":"4"}},{"id":2132388,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-26T01:30:13.000Z","date":"2022-10-24","kind":"sale","acquired":false,"shares":29400,"price":4.98,"value":146412.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $5.35, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14331960,"source":{"system":"sec-edgar","filing":"0000899243-22-034156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034156/doc4.xml","form_type":"4"}},{"id":2132387,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-26T01:30:13.000Z","date":"2022-10-21","kind":"sale","acquired":false,"shares":20000,"price":4.96,"value":99200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.64 to $5.12, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14361360,"source":{"system":"sec-edgar","filing":"0000899243-22-034156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322034156/doc4.xml","form_type":"4"}},{"id":2134190,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-21T01:30:13.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":12000,"price":4.83,"value":57960.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.51 to $5.12, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14381360,"source":{"system":"sec-edgar","filing":"0000899243-22-033908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033908/doc4.xml","form_type":"4"}},{"id":2134189,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-21T01:30:13.000Z","date":"2022-10-19","kind":"sale","acquired":false,"shares":17500,"price":4.68,"value":81900.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.45 to $4.82, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14393360,"source":{"system":"sec-edgar","filing":"0000899243-22-033908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033908/doc4.xml","form_type":"4"}},{"id":2134188,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-21T01:30:13.000Z","date":"2022-10-18","kind":"sale","acquired":false,"shares":12200,"price":4.63,"value":56486.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.44 to $4.92, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14410860,"source":{"system":"sec-edgar","filing":"0000899243-22-033908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033908/doc4.xml","form_type":"4"}},{"id":2136390,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-18T01:30:13.000Z","date":"2022-10-17","kind":"sale","acquired":false,"shares":8249,"price":4.6,"value":37945.4,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.38 to $4.74, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14423060,"source":{"system":"sec-edgar","filing":"0000899243-22-033713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033713/doc4.xml","form_type":"4"}},{"id":2136389,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-18T01:30:13.000Z","date":"2022-10-14","kind":"sale","acquired":false,"shares":9800,"price":4.54,"value":44492.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.22 to $4.77, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14431309,"source":{"system":"sec-edgar","filing":"0000899243-22-033713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033713/doc4.xml","form_type":"4"}},{"id":2136388,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-18T01:30:13.000Z","date":"2022-10-13","kind":"sale","acquired":false,"shares":25200,"price":4.67,"value":117684.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.77, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14441109,"source":{"system":"sec-edgar","filing":"0000899243-22-033713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033713/doc4.xml","form_type":"4"}},{"id":2138359,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-13T01:30:10.000Z","date":"2022-10-12","kind":"sale","acquired":false,"shares":14343,"price":4.7,"value":67412.1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.86, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any Security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14466309,"source":{"system":"sec-edgar","filing":"0000899243-22-033524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033524/doc4.xml","form_type":"4"}},{"id":2138358,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-13T01:30:10.000Z","date":"2022-10-11","kind":"sale","acquired":false,"shares":25000,"price":4.66,"value":116500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.85, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14480652,"source":{"system":"sec-edgar","filing":"0000899243-22-033524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033524/doc4.xml","form_type":"4"}},{"id":2138357,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-13T01:30:10.000Z","date":"2022-10-10","kind":"sale","acquired":false,"shares":21500,"price":4.33,"value":93095.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.01 to $4.61, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14505652,"source":{"system":"sec-edgar","filing":"0000899243-22-033524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033524/doc4.xml","form_type":"4"}},{"id":2140506,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-08T01:30:27.000Z","date":"2022-10-07","kind":"sale","acquired":false,"shares":14652,"price":4.63,"value":67838.76,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.51 to $4.73, \tinclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the \tSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth \tin footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14527152,"source":{"system":"sec-edgar","filing":"0000899243-22-033327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033327/doc4.xml","form_type":"4"}},{"id":2140505,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-08T01:30:27.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":33509,"price":4.45,"value":149115.05,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.84, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14541804,"source":{"system":"sec-edgar","filing":"0000899243-22-033327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033327/doc4.xml","form_type":"4"}},{"id":2140504,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-08T01:30:27.000Z","date":"2022-10-05","kind":"sale","acquired":false,"shares":14060,"price":4.78,"value":67206.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.51 to $4.85, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14575313,"source":{"system":"sec-edgar","filing":"0000899243-22-033327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322033327/doc4.xml","form_type":"4"}},{"id":2144878,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-05T01:31:13.000Z","date":"2022-10-04","kind":"sale","acquired":false,"shares":23447,"price":4.85,"value":113717.95,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $5.05, inclusive. The \treporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange \tCommission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14589373,"source":{"system":"sec-edgar","filing":"0000899243-22-032851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032851/doc4.xml","form_type":"4"}},{"id":2144877,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-05T01:31:13.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":16765,"price":4.72,"value":79130.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.89, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14612820,"source":{"system":"sec-edgar","filing":"0000899243-22-032851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032851/doc4.xml","form_type":"4"}},{"id":2144876,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-10-05T01:31:13.000Z","date":"2022-09-30","kind":"sale","acquired":false,"shares":11000,"price":4.68,"value":51480.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.45 to $4.78, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14629585,"source":{"system":"sec-edgar","filing":"0000899243-22-032851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032851/doc4.xml","form_type":"4"}},{"id":2149417,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-30T01:30:14.000Z","date":"2022-09-29","kind":"sale","acquired":false,"shares":21000,"price":4.62,"value":97020.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.74, inclusive. \tThe reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14640585,"source":{"system":"sec-edgar","filing":"0000899243-22-032266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032266/doc4.xml","form_type":"4"}},{"id":2149416,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-30T01:30:14.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":12642,"price":4.72,"value":59670.24,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.49 to $4.85, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14661585,"source":{"system":"sec-edgar","filing":"0000899243-22-032266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032266/doc4.xml","form_type":"4"}},{"id":2149415,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-30T01:30:14.000Z","date":"2022-09-27","kind":"sale","acquired":false,"shares":14074,"price":4.69,"value":66007.06,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.45 to $4.84, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14674227,"source":{"system":"sec-edgar","filing":"0000899243-22-032266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032266/doc4.xml","form_type":"4"}},{"id":2151300,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-27T01:30:13.000Z","date":"2022-09-26","kind":"sale","acquired":false,"shares":7153,"price":4.57,"value":32689.21,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 to $4.78, inclusive. \tThe reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14688301,"source":{"system":"sec-edgar","filing":"0000899243-22-032050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032050/doc4.xml","form_type":"4"}},{"id":2151299,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-27T01:30:13.000Z","date":"2022-09-23","kind":"sale","acquired":false,"shares":5375,"price":4.19,"value":22521.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.02 to $4.30, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14695454,"source":{"system":"sec-edgar","filing":"0000899243-22-032050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032050/doc4.xml","form_type":"4"}},{"id":2151298,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-27T01:30:13.000Z","date":"2022-09-22","kind":"sale","acquired":false,"shares":13086,"price":4.25,"value":55615.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.14 to $4.39, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14700829,"source":{"system":"sec-edgar","filing":"0000899243-22-032050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322032050/doc4.xml","form_type":"4"}},{"id":2155847,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-20T01:30:11.000Z","date":"2022-09-19","kind":"sale","acquired":false,"shares":19629,"price":4.33,"value":84993.57,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.01 to $4.51, \tinclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the \tSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set \tforth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14713915,"source":{"system":"sec-edgar","filing":"0000899243-22-031553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322031553/doc4.xml","form_type":"4"}},{"id":2155846,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-20T01:30:11.000Z","date":"2022-09-16","kind":"sale","acquired":false,"shares":200000,"price":4.5,"value":900000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.77, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14733544,"source":{"system":"sec-edgar","filing":"0000899243-22-031553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322031553/doc4.xml","form_type":"4"}},{"id":2155845,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-20T01:30:11.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":68500,"price":4.55,"value":311675.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.90, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":14933544,"source":{"system":"sec-edgar","filing":"0000899243-22-031553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322031553/doc4.xml","form_type":"4"}},{"id":2159414,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-15T01:30:10.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":37785,"price":4.99,"value":188547.15,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.86 to $5.30, inclusive. \tThe reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities \tand Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote \t(3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15002044,"source":{"system":"sec-edgar","filing":"0000899243-22-031089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322031089/doc4.xml","form_type":"4"}},{"id":2159413,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-15T01:30:10.000Z","date":"2022-09-13","kind":"sale","acquired":false,"shares":52500,"price":5.28,"value":277200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.47, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15039829,"source":{"system":"sec-edgar","filing":"0000899243-22-031089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322031089/doc4.xml","form_type":"4"}},{"id":2159412,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-15T01:30:10.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":38000,"price":5.52,"value":209760.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.12 to $5.88, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15092329,"source":{"system":"sec-edgar","filing":"0000899243-22-031089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322031089/doc4.xml","form_type":"4"}},{"id":2162352,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-10T01:30:15.000Z","date":"2022-09-09","kind":"sale","acquired":false,"shares":18900,"price":5.8,"value":109620.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.70 to $5.96, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15130329,"source":{"system":"sec-edgar","filing":"0000899243-22-030763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030763/doc4.xml","form_type":"4"}},{"id":2162351,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-10T01:30:15.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":23500,"price":6.04,"value":141940.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.77 to $6.17, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15149229,"source":{"system":"sec-edgar","filing":"0000899243-22-030763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030763/doc4.xml","form_type":"4"}},{"id":2162350,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-10T01:30:15.000Z","date":"2022-09-07","kind":"sale","acquired":false,"shares":45000,"price":6.04,"value":271800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.62 to $6.18, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15172729,"source":{"system":"sec-edgar","filing":"0000899243-22-030763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030763/doc4.xml","form_type":"4"}},{"id":2165788,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-07T01:30:15.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":84200,"price":5.91,"value":497622.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.65 to $6.27, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15217729,"source":{"system":"sec-edgar","filing":"0000899243-22-030551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030551/doc4.xml","form_type":"4"}},{"id":2165787,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-07T01:30:15.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":41783,"price":6.03,"value":251951.49,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.91 to $6.21, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15301929,"source":{"system":"sec-edgar","filing":"0000899243-22-030551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030551/doc4.xml","form_type":"4"}},{"id":2165786,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-07T01:30:15.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":31500,"price":6.16,"value":194040.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.38, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15343712,"source":{"system":"sec-edgar","filing":"0000899243-22-030551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030551/doc4.xml","form_type":"4"}},{"id":2170019,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-01T01:30:10.000Z","date":"2022-08-31","kind":"sale","acquired":false,"shares":25000,"price":6.36,"value":159000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.09 to $6.51, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15375212,"source":{"system":"sec-edgar","filing":"0000899243-22-030146","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030146/doc4.xml","form_type":"4"}},{"id":2170018,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-01T01:30:10.000Z","date":"2022-08-30","kind":"sale","acquired":false,"shares":38500,"price":6.19,"value":238315.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.92 to $6.51, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15400212,"source":{"system":"sec-edgar","filing":"0000899243-22-030146","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030146/doc4.xml","form_type":"4"}},{"id":2170017,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-09-01T01:30:10.000Z","date":"2022-08-29","kind":"sale","acquired":false,"shares":15000,"price":6.14,"value":92100.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.91 to $6.32, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15438712,"source":{"system":"sec-edgar","filing":"0000899243-22-030146","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322030146/doc4.xml","form_type":"4"}},{"id":2172966,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-27T01:30:20.000Z","date":"2022-08-26","kind":"sale","acquired":false,"shares":40000,"price":6.03,"value":241200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.85 to $6.27, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15453712,"source":{"system":"sec-edgar","filing":"0000899243-22-029900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322029900/doc4.xml","form_type":"4"}},{"id":2172965,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-27T01:30:20.000Z","date":"2022-08-25","kind":"sale","acquired":false,"shares":3525,"price":6.2,"value":21855.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.40, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15493712,"source":{"system":"sec-edgar","filing":"0000899243-22-029900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322029900/doc4.xml","form_type":"4"}},{"id":2172964,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-27T01:30:20.000Z","date":"2022-08-24","kind":"sale","acquired":false,"shares":21084,"price":6.37,"value":134305.08,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.68, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15497237,"source":{"system":"sec-edgar","filing":"0000899243-22-029900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322029900/doc4.xml","form_type":"4"}},{"id":2176183,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-24T01:30:15.000Z","date":"2022-08-23","kind":"sale","acquired":false,"shares":48100,"price":6.54,"value":314574.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.35 to $6.69, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15518321,"source":{"system":"sec-edgar","filing":"0000899243-22-029569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322029569/doc4.xml","form_type":"4"}},{"id":2176182,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-24T01:30:15.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":35500,"price":6.53,"value":231815.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.31 to $6.66, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15566421,"source":{"system":"sec-edgar","filing":"0000899243-22-029569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322029569/doc4.xml","form_type":"4"}},{"id":2176181,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-24T01:30:15.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":10873,"price":6.81,"value":74045.13,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.67 to $6.99, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15601921,"source":{"system":"sec-edgar","filing":"0000899243-22-029569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322029569/doc4.xml","form_type":"4"}},{"id":2184440,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-17T01:30:14.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":8437,"price":6.4,"value":53996.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.06 to $6.62, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15612794,"source":{"system":"sec-edgar","filing":"0000899243-22-028883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322028883/doc4.xml","form_type":"4"}},{"id":2184439,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-17T01:30:14.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":16663,"price":6.23,"value":103810.49,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.50, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15621231,"source":{"system":"sec-edgar","filing":"0000899243-22-028883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322028883/doc4.xml","form_type":"4"}},{"id":2184438,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":88187,"kind":"organization","name":"Havencrest Healthcare Partners, L.P.","position":1,"cik":"0001705748","reported_name":"Havencrest Healthcare Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88188,"kind":"organization","name":"Havencrest Healthcare Partners GP, LLC","position":2,"cik":"0001893722","reported_name":"Havencrest Healthcare Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88189,"kind":"organization","name":"TOI HC I, LLC","position":3,"cik":"0001892154","reported_name":"TOI HC I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2022-08-17T01:30:14.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":24900,"price":6.69,"value":166581.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $7.02, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":15637894,"source":{"system":"sec-edgar","filing":"0000899243-22-028883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000089924322028883/doc4.xml","form_type":"4"}}]}